NASDAQ:BNGO | Free Cash Flow | Bionano Genomics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$5.72M
2025-12-31-$4.18M
2025-03-31-$2.76M
2024-12-31-$6.5M
2024-03-31-$28.13M
2023-12-31-$29.78M
2023-03-31-$32.41M
2022-12-31-$34.52M
2022-03-31-$32.49M
2021-12-31-$25.62M
2021-03-31-$13.9M$24,000.00-$13.93M
2020-12-31-$12.1M$0.00-$12.1M
2020-03-31-$8.03M$0.00-$8.03M
2019-12-31-$9.38M$23,056.00-$9.4M
2019-03-31-$6.55M$0.00-$6.55M
2018-12-31-$4.09M$11,831.00-$4.1M
2018-03-31-$6.79M$11,830.00-$6.8M
2017-12-31-$2.81M$281,767.00-$3.09M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$16.35M
2024-12-31-$68.92M
2023-12-31-$125.18M
2022-12-31-$124.82M
2021-12-31-$71.93M
2020-12-31-$38.31M$0.00-$38.31M
2019-12-31-$29.53M$61,056.00-$29.59M
2018-12-31-$19.94M$331,716.00-$20.28M
2017-12-31-$20.82M$1.02M-$21.84M